Showing results (331-340 of 357) with videos related to
Sort By:
Pageof 36
Pharmacological Reviews|March 27, 2025
Cell cycle dysregulation in cancerAntonino Glaviano, Samarendra K Singh, E Hui Clarissa Lee, et al.Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2025
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic SarcomasBreelyn A Wilky, Gary K Schwartz, Michael S Gordon, et al.Gastroenterology|October 15, 2013
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.Journal of the American Geriatrics Society|December 11, 2021
Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A StudySergio Salmerón Ríos, Elisa Belén Cortés Zamora, Almudena Avendaño Céspedes, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatmentAntonino Glaviano, Seth A Wander, Richard D Baird, et al.EMBO Molecular Medicine|May 31, 2020
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patientsJustin Stebbing, Venkatesh Krishnan, Stephanie de Bono, et al.Oncogene|November 28, 2018
The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic interventionAlexander Renziehausen, Hexiao Wang, Bhavya Rao, et al.Experimental Hematology & Oncology|December 1, 2023
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary diseaseMireia Mato Prado, Jisce R Puik, Leandro Castellano, et al.Respiratory Research|April 2, 2024
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDSIoannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, et al.Pageof 36